Across disease status
How the selected metric shifts among healthy, primary, metastatic, and non-cancer disease samples.
Loading...
| Group | Median | Samples |
|---|---|---|
| Primary cancer | 461.5209.5-1,022 | 33 |
| Healthy/control | 21491.75-515.25 | 11 |
How the selected metric shifts among healthy, primary, metastatic, and non-cancer disease samples.
| Group | Median | Samples |
|---|---|---|
| Primary cancer | 461.5209.5-1,022 | 33 |
| Healthy/control | 21491.75-515.25 | 11 |
How the same metric changes across tissue contexts after the current filters and tier are applied.
| Group | Median | Samples |
|---|---|---|
| Lymphoid tissue | 6,8075,918-12,415 | 1 |
| Breast | 393.5163.5-828.25 | 41 |
| Liver | 214122.75-269.25 | 2 |
The combined comparison, useful for separating disease effects from tissue composition.
| Group | Median | Samples |
|---|---|---|
| Primary cancer × Lymphoid tissue | 6,8075,918-12,415 | 1 |
| Primary cancer × Breast | 441205.25-914.5 | 32 |
| Healthy/control × Liver | 214122.75-269.25 | 2 |
| Healthy/control × Breast | 213.585.25-560 | 9 |
| Group | Metric | Mean | Samples | Datasets |
|---|---|---|---|---|
| Primary cancer | Domain size | 1,028 | 33 | 2 |
| Healthy/control | Domain size | 331.94 | 11 | 1 |